Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • Safety and tolerability of nin...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice

Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice

Bibliographic Details
Main Authors: Sophie V. Fletcher, Mark G. Jones, Elizabeth A. Renzoni, Helen Parfrey, Rachel K. Hoyles, Katherine Spinks, Maria Kokosi, Apollinaris Kwok, Chris Warburton, Vanessa Titmuss, Muhunthan Thillai, Nicola Simler, Toby M. Maher, Christopher J. Brereton, Felix Chua, Athol U. Wells, Luca Richeldi, Lisa G. Spencer
Format: Article
Language:English
Published: European Respiratory Society 2018-10-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/4/4/00049-2018.full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://openres.ersjournals.com/content/4/4/00049-2018.full

Similar Items

  • Nintedanib in the treatment of idiopathic pulmonary fibrosis
    by: Mariano E. Mazzei, et al.
    Published: (2015-06-01)
  • Identification of antigen-specific T-cells and protein biomarkers for diagnosis of sarcoidosis
    by: Thillai, Muhunthan
    Published: (2012)
  • Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage
    by: Christopher J. Ryerson, et al.
    Published: (2019-04-01)
  • Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
    by: Luca Richeldi, et al.
    Published: (2020-01-01)
  • Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
    by: Vincent Cottin, et al.
    Published: (2021-03-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...